PTH and secondary hyperparathyroidism: Secondary hyperparathyroidism (SHPT), characterized by the elevation of serum parathyroid hormone (PTH) levels, is a common disorder in patients with chronic kidney disease (CKD), especially those on renal replacement therapy [1].